In a woman receiving estrogen therapy who has a low morning cortisol of 6 µg/dL, does estrogen influence the result and what is the appropriate next step?

Yes, Estrogen Therapy Significantly Affects Cortisol Interpretation

The morning cortisol of 6 µg/dL is likely falsely low due to estrogen therapy, and the next step is to measure ACTH and consider dynamic testing with an ACTH stimulation test, or alternatively switch to transdermal estrogen and retest.

Understanding the Estrogen Effect

Oral estrogen therapy increases cortisol-binding globulin (CBG) levels, which paradoxically can make total serum cortisol measurements appear elevated in most cases 1, 2. However, the guidelines explicitly state that "certain clinical situations cause elevated cortisol levels: estrogen administration, pregnancy and all acute intercurrent diseases. In these situations, diagnosis must rest on higher threshold levels of cortisol and/or on a group of assumptions (case history, ACTH and renin levels)" 1.

The key issue here is that your patient has a low cortisol of 6 µg/dL (approximately 165 nmol/L), which falls in the diagnostic gray zone even accounting for estrogen effects:

• Below 5 µg/dL (138 nmol/L): Makes adrenal insufficiency very likely 1
• 5-18 µg/dL (138-500 nmol/L): Intermediate zone requiring stimulation testing 1
• Above 18 µg/dL (500 nmol/L): Makes adrenal insufficiency unlikely 1

Critical Next Steps

1. Measure ACTH Immediately

Check a simultaneous ACTH level to distinguish primary from secondary adrenal insufficiency 1, 3:

• Low ACTH with low cortisol = secondary (central) adrenal insufficiency
• Elevated ACTH (>2x upper limit) = primary adrenal insufficiency 4

2. Perform ACTH Stimulation Test

Proceed with a standard 250 µg cosyntropin (Synacthen) stimulation test 1, 4:

• Measure cortisol at baseline, 30, and 60 minutes post-injection
• Peak cortisol <18 µg/dL (500 nmol/L) confirms adrenal insufficiency 1
• This test remains valid even on estrogen therapy, though interpretation requires clinical context

3. Consider Alternative Testing Approaches

Given the estrogen confounding:

Option A: Switch to transdermal estrogen first

• Transdermal estrogen does not significantly affect CBG or total cortisol levels 5, 6
• Retest morning cortisol after switching (allow 4 weeks for oral estrogen effects to normalize 7)
• This provides cleaner interpretation without stopping hormone therapy

Option B: Measure salivary cortisol

• Salivary cortisol reflects free (unbound) cortisol and is not affected by CBG changes 5, 6
• Recent research shows salivary cortisol decreased on oral estrogen while total cortisol increased 5
• This may provide more accurate assessment of true adrenal function

Option C: Stop oral estrogen temporarily

• If stopping is feasible, wait 4 weeks minimum for CBG and cortisol normalization 7
• Previous recommendations of 6 weeks can be shortened to 4 weeks based on recent evidence 7

Clinical Context Matters

Assess for Symptoms of Adrenal Insufficiency

Look specifically for:

• Fatigue, weakness, weight loss
• Orthostatic hypotension
• Hyponatremia (check electrolytes)
• Hypoglycemia episodes
• Hyperpigmentation (if primary AI)

If symptomatic: Start hydrocortisone replacement immediately (15-20 mg daily in divided doses) while completing diagnostic workup 1, 3, 1. The guideline states "replacement therapy for primary adrenal insufficiency or ACTH insufficiency must be commenced as soon as the diagnosis is suspected and continued until the diagnosis is confirmed or excluded" 1.

Important Caveats

• Assay variability: Different cortisol assays have different cutoffs; know your laboratory's reference ranges 2
• Timing matters: Ensure the sample was truly drawn in the morning (7-8 AM) when cortisol peaks 1
• Circadian disruption: Night shift work, jet lag, or severe insomnia can falsely lower morning cortisol 2

The Bottom Line Algorithm

1. Check ACTH now (with repeat morning cortisol if needed)
2. Perform 250 µg ACTH stimulation test
3. If peak cortisol <18 µg/dL: Diagnose adrenal insufficiency and start replacement
4. If borderline (18-20 µg/dL): Consider switching to transdermal estrogen and retesting, or use salivary cortisol
5. If clearly normal (>20 µg/dL): Reassure and monitor clinically

The estrogen effect typically raises total cortisol, so a low value of 6 µg/dL despite estrogen therapy is concerning and warrants thorough evaluation rather than dismissal as artifact 1, 2.